The latest Investing Matters Podcast episode featuring Jeremy Skillington, CEO of Poolbeg Pharma has just been released. Listen here.

Less Ads, More Data, More Tools Register for FREE

Pin to quick picksClontarf Regulatory News (CLON)

Share Price Information for Clontarf (CLON)

London Stock Exchange
Share Price is delayed by 15 minutes
Get Live Data
Share Price: 0.0375
Bid: 0.035
Ask: 0.04
Change: 0.00 (0.00%)
Spread: 0.005 (14.286%)
Open: 0.0375
High: 0.0375
Low: 0.0375
Prev. Close: 0.0375
CLON Live PriceLast checked at -

Watchlists are a member only feature

Login to your account

Alerts are a premium feature

Login to your account

Conversion of Director Loans

21 Jul 2014 10:02

RNS Number : 8415M
Clontarf Energy PLC
21 July 2014
 



 

21 July 2014

Clontarf Energy plc

("Clontarf" or "the Company")

 

Conversion of Directors Loans

 

Directors Shareholdings

 

Clontarf announced this morning the intended conversion of directors loans, in order to strengthen the Company's balance sheet. Conditional upon admission the Board has issued 70,302,632 new ordinary shares in repayment of these directors loans and accrued remuneration totalling £409,382 and £117,888 respectively ("the Directors Loan Shares") at a price of 0.75p per Directors Loan Share.

 

The Directors Loan Shares will be issued as shown in the table below.

 

Director

Directors Loan Shares

John Teeling

31,906,122

David Horgan

11,108,655

James Finn

27,287,855

 

Related Party Transaction

 

The issue of the Directors Loan Shares is a related party transaction under the AIM Rules for Companies. There are no independent directors for the purposes of providing the fair and reasonable opinion under Rule 13 of the AIM Rules for Companies. Northland Capital Partners Limited, the Company's Nominated Adviser, considers that the terms of the issue of the Directors Loan Shares are fair and reasonable so far as the shareholders of the Company are concerned.

 

Enlarged Share Capital

 

Application will be made for the Directors Loan Shares to be admitted to trading on AIM ("Admission"). Admission is expected to be effective on 28 July 2014. Following Admission of the Directors Loan Shares together with the Placing Shares and Creditor Shares as announced earlier this morning, the Company's issued share capital will consist of 382,797,210 ordinary shares, with each ordinary share carrying the right to one vote. The Company does not hold any ordinary shares in treasury. This figure of 382,797,210 may therefore be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

 

Furthermore, the Company confirms that John Teeling, Executive Chairman, has today disposed of 16,000,000 ordinary shares to family members at a price of 0.75p per share (the "Disposal").

 

Following the issue of the Directors Loan Shares and the Disposal the resultant shareholdings of the Board of the Company are as follows.

 

Director

Existing shareholding

Directors Loan Shares

Disposal

Resultant shareholding

% of enlarged share capital

John Teeling

22,286,633

31,906,122

16,000,000

38,192,755

9.98

David Horgan

10,842,233

11,108,655

21,950,888

5.73

James Finn

11,024,867

27,287,855

38,312,722

10.01

 

 

South American Investors

 

Further to the announcement made by the Company on 17 July 2014, the Company confirms that the 79,767,067 ordinary shares issued to its South American lenders and due for admission to trading on AIM on 24 July 2014 are the subject of lock-ins for a period of twelve months expiring 17 July 2015.

 

 

 

ENDS

 

 

For further information please visit http://clontarfenergy.com or contact:

 

Clontarf Energy plc

John Teeling, Chairman +353 (0) 1 833 2833

James Finn, Director

 

Nominated Adviser and Broker

Northland Capital Partners Limited

Gavin Burnell / Lauren Kettle +44 (0)20 7382 1100

Alice Lane / John Howes (Broking)

 

 

Public Relations

Blytheweigh +44 (0)20 7138 3204

Tim Blythe +44 (0) 7816 924 626

Halimah Hussain +44 (0) 7725 978 141

Camilla Horsfall +44 (0) 7871 841 793

 

 

Pembroke Communications

Natalie Tennyson +353 (0) 1 649 6486

Alan Tyrrell +353 (0) 1 649 6486

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
RDSKMGZNRMLGDZG
Date   Source Headline
10th Apr 20241:35 pmRNSGrant of Share Options
18th Mar 20247:00 amRNSBolivia Update, Fundraising and TVR
6th Mar 202410:33 amRNSEncouraging Bolivian Brines Progress
5th Feb 20247:00 amRNSSouth American Brines Progress
25th Sep 20237:00 amRNSInterim Results for the period ended 30 June 2023
1st Aug 202310:38 amRNSGrant of Share Options
13th Jul 202312:35 pmRNSResult of AGM and Corporate Update
22nd Jun 202312:32 pmRNSPosting of Annual Report and Notice of AGM
8th Jun 20237:00 amRNSPreliminary Results
1st Jun 20237:00 amRNS£350,000 Fundraising and Corporate Update
5th May 20237:00 amRNSUpdate on Joint Venture Agreement and TVR
28th Mar 202310:24 amRNSJV Agreement on Direct Lithium Extraction Bolivia
17th Feb 202311:05 amRNSSecond Price Monitoring Extn
17th Feb 202311:00 amRNSPrice Monitoring Extension
15th Feb 20237:00 amRNSJV HoA on Direct Lithium Ion Extraction in Bolivia
17th Jan 202310:34 amRNSGrant of Share Options
16th Jan 20237:00 amRNS£1.3 million Fundraising and Corporate Update
8th Nov 20224:40 pmRNSSecond Price Monitoring Extn
8th Nov 20224:35 pmRNSPrice Monitoring Extension
22nd Sep 20227:00 amRNSInterim Results for the period ended 30 June 2022
5th Sep 20227:02 amRNSShare Price Movement and Shareholder Update
4th Aug 20221:00 pmRNSResult of AGM and Capital Reorganisation
1st Jul 202211:04 amRNSDirector Change
29th Jun 202210:30 amRNSPosting of Annual Report
22nd Jun 20227:00 amRNSPreliminary Results for the Year Ended 31 Dec 2021
14th Jun 20227:00 amRNSSasanof-1 well completion
6th Jun 20227:00 amRNSSasanof-1 well final result
6th Jun 20227:00 amRNSResult of General Meeting
30th May 20228:00 amRNSSasanof-1 well drilling update
27th May 20227:00 amRNSSasanof-1 well spudding
23rd May 20227:00 amRNSSasanof-1 well mobilisation update
20th May 20224:41 pmRNSSecond Price Monitoring Extn
20th May 20224:36 pmRNSPrice Monitoring Extension
18th May 20222:06 pmRNSSecond Price Monitoring Extn
18th May 20222:00 pmRNSPrice Monitoring Extension
18th May 20227:00 amRNSSasanof-1 well mobilisation update
17th May 202211:00 amRNSPrice Monitoring Extension
12th May 202211:53 amRNSUpdate on Sasanof-1 well
11th May 20223:58 pmRNSNotice of General Meeting
10th May 20227:00 amRNSConsideration Shares to be Admitted to Trading
9th May 20227:00 amRNSAcquisition of 10% of Sasanof Prospect
27th Apr 20221:02 pmRNSPlacing to raise £3,500,000
12th Jan 20224:40 pmRNSIssue of Warrants and RPT
20th Sep 20214:41 pmRNSSecond Price Monitoring Extn
20th Sep 20214:36 pmRNSPrice Monitoring Extension
15th Sep 20217:00 amRNSInterim Statement
23rd Jun 202111:35 amRNSResult of Annual General Meeting and Board Changes
7th Jun 202110:50 amRNSPosting of Annual Report and Notice of AGM
24th May 20214:11 pmRNSTR-1: Notification of major holdings
20th May 20213:58 pmRNSTR-1: Notification of major holdings

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.